The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca (Inst); janssen oncology (Inst)
Speakers' Bureau - IPSEN (Inst); Medtalks (Inst)
Infrastructure for rare cancer in the Netherlands: Towards a comprehensive platform for early detection and diagnosis of rare cancers (FORCE).
 
Carolina R.C. Pieterman
No Relationships to Disclose
 
Nathalie van den Tempel
No Relationships to Disclose
 
Marcus W Dercksen
No Relationships to Disclose
 
Koen MA Dreijerink
Consulting or Advisory Role - HRA Pharma; Novartis
Speakers' Bureau - Ipsen
Research Funding - Besins Healthcare (Inst)
Travel, Accommodations, Expenses - Ipsen
 
Rudolf Stephan Nicolaas Fehrmann
No Relationships to Disclose
 
Wouter W. de Herder
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen
Speakers' Bureau - Advanced Accelerator Applications; Ipsen; Novartis
Research Funding - Ipsen
Travel, Accommodations, Expenses - Ipsen
 
Johannes Hofland
No Relationships to Disclose
 
Mathilde Jalving
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Pierre Fabre
 
Heinz-Josef Klümpen
No Relationships to Disclose
 
Loes M Latten-Jansen
No Relationships to Disclose
 
Luc Linden
No Relationships to Disclose
 
Els JM Nieveen van Dijkum
No Relationships to Disclose
 
Michiel B de Ruiter
No Relationships to Disclose
 
Ed Schuuring
Honoraria - Agena Bioscience (Inst); Bio-Rad (Inst); Biocartis (Inst); Illumina (Inst); Jansen-Cilag (Inst); Lilly (Inst); Roche (Inst)
Consulting or Advisory Role - Agena Bioscience (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Diaceutics (Inst); GlaxoSmithKline (Inst); Illumina (Inst); Janssen Cilag (Johnson&Johnson (Inst); Lilly (Inst); MSD/Merck (Inst); Roche (Inst)
Research Funding - Abbott (Inst); Agena Bioscience (Inst); AstraZeneca (Inst); Bio-Rad (Inst); Biocartis (Inst); CC Diagnostics (Inst); Invitae/ArcherDx (Inst); Qiagen (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Agena Bioscience; Bio-Rad; Roche Molecular Diagnostics
 
Marga Schrieks
No Relationships to Disclose
 
Morris A Swertz
No Relationships to Disclose
 
Margot ET Tesselaar
No Relationships to Disclose
 
Dirk J Veldman
No Relationships to Disclose
 
Gerlof D Valk
No Relationships to Disclose
 
Anna Maria Elisabeth Walenkamp
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - IPSEN (Inst)